UBS Group’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.15M | Buy |
|
|||||
|
2025
Q1 | $2.45M | Sell |
|
|||||
|
2024
Q4 | $4.32M | Buy |
|
|||||
|
2024
Q3 | $105K | Sell |
|
|||||
|
2024
Q2 | $444K | Sell |
|
|||||
|
2024
Q1 | $556K | Buy |
|
|||||
|
2023
Q4 | $201 | Sell |
|
|||||
|
2023
Q3 | $3.41K | Sell |
|
|||||
|
2023
Q2 | $1.99M | Buy |
|
|||||
|
2023
Q1 | $711K | Buy |
|
|||||
|
2022
Q4 | $461K | Buy |
|
|||||
|
2022
Q3 | $59K | Buy |
|
|||||
|
2022
Q2 | $1K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $18K | Buy |
|